alert-en Icon

Winter Weather Alert: Some locations, classes, and events may have adjusted hours or closures. Please call ahead for updates. Stay safe!

Melanoma

 

Melanoma Oncology Research Studies

RANDOMIZED PHASE II/III STUDY OF NIVOLUMAB PLUS IPILIMUMAB PLUS SARGRAMOSTIM VERSUS NIVOLUMAB PLUS IPILIMUMAB IN PATIENTS WITH UNRESECTABLE STAGE III OR STAGE IV MELANOMA
EA6141

Contact Us

Give us a call to learn more about our oncology research studies.